ArticleCellular oncology (Dordrecht, Netherlands)2017

Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.

Sirichat Kaowinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.